Our Work Experience

Needs Assessment to Support MASLD: A Call to Action initiative

We designed and executed a national needs assessment to identify where clinician practice diverges from current MASLD/MASH* guidance and where education could most effectively drive change. In total, 751 gastroenterologists, hepatologists, endocrinologists, and primary care providers completed the needs assessment survey. The findings identified participants’ knowledge gaps related to screening, diagnosis, and management of the diseases; benchmarked diagnostic and treatment patterns against practice guidance; and identified the educational needs to improve implementation of guideline-based treatment.

* Metabolic dysfunction-associated steatotic liver disease (MASLD) is formely known as nonalcoholic fatty liver disease or NAFLD); metabolic dysfunction-associated steatohepatitis (MASH) is formerly known as nonalcoholic steatohepatitis or NASH.

Strategic Stakeholder Mapping and Prioritization

We helped a global pharmaceutical company to assess the current state of medical education in obesity and prioritize opportunities to expand obesity education through medical professional associations with non-metabolic specialties, health systems, and universities in thirteen Northwestern European countries. We conducted in-depth interviews with internal stakeholders in each country, identified 34 organizations to profile, developed analytical framework, and conducted desk research and follow up interviews with organizations. In the end, we identified top advocates for medical education in obesity in each country and opportunities for direct and indirect collaboration with the pharmaceutical company.

C4C conducted similar studies with other audience segments (e.g., patient advocacy organizations, government agencies and regulatory bodies, multi-stakeholder alliances) internationally and domestically.   

Mobile Point-of-Care App for the Index of Severity for Eosinophilic Esophagitis

We conducted usability testing of a new point-of-care mobile application that enables clinicians to calculate the Index of Severity for Eosinophilic Esophagitis (I-SEE). Sixty clinicians, including adult and pediatric gastroenterologists and allergists, used the app with EoE patients in routine practice and participated in in-depth qualitative interviews. Despite limited prior exposure to I-SEE, clinicians reported that the app was intuitive, easy to navigate, and could be completed in just minutes during clinical encounters, resulting in high satisfaction across specialties. Qualitative insights identified clear opportunities to further reduce friction and strengthen clinical impact, including design enhancements, electronic medical record integration, clarification of pediatric versus adult scoring, and stronger connections between severity scores and treatment decisions.

Confidence in Hereditary Cancer Discussion for Primary Care Providers

In partnership with the Family Medicine Education Consortium and the National Association of Chronic Disease Directors, we developed a seven-part, AAFP-accredited CME series to strengthen family physicians’ confidence and skills in identifying and managing patients at increased risk for hereditary breast cancer. The Confidence in Hereditary Cancer Discussion for Primary Care Providers series addresses common barriers to screening, referral, and patient communication. Each 15-minute module focuses on a key practice area, including using narrative medicine to discuss genetic risk, integrating screening and referral into primary care workflows, collaborating with genetic counselors, and supporting patients’ concerns around insurance, disclosure, and family communication.